Objective: The morphological interpretation of liquid-based preparation (LBP) remains a diagnostic challenge due to altered cytomorphology with technical reason. Only a few published accounts of the cytopathological features needed for diagnosis of papillary thyroid carcinoma (PTC) on an LBP exist. We utilized the SurePath LBP system to evaluate conventional and newly recognized cytomorphologic features on histologically confirmed PTC to identify their potent diagnostic significance compared to benign follicular neoplasm (BFN). Study Design: One-hundred and three cases of PTC and 84 BFNs were collected using preoperative fine needle aspiration biopsies. We evaluated and compared 16 cytomorphologic findings in PTC and BFN using an LBP. Results: Among the conventional criteria, papillary structures, fewer background colloids and macrophages, hobnail patterns (54.4% in PTC vs. 10.7% in BFN; p < 0.001) and swirling architecture (14.6% in PTC vs. 0% in BFN; p < 0.001; positive predictive value 100.0%) were significant diagnostic findings for PTC compared to BFN. The hobnail pattern was shown as a newly recognized strong diagnostic parameter for PTC (odds ratio 50.157, p < 0.001). Conclusion: The identified distinctive cytological criteria may be helpful in cases where conventional criteria for PTC are insufficient. Furthermore, application of these findings, along with classical criteria, may enhance the diagnostic accuracy of PTC by fine needle aspiration biopsy.

Keywords:
Liquid-based cytology, SurePath, Fine needle aspiration, Cytomorphology, Papillary thyroid carcinoma
1.
Stamataki M, Anninos D, Brountzos E, Georgoulakis J, Panayiotides J, Christoni Z, Peros G, Karakitsos P: The role of liquid-based cytology in the investigation of thyroid lesions. Cytopathology 2008;19:11-18.
2.
Ljung BM: Thyroid fine-needle aspiration: smears versus liquid-based preparations. Cancer 2008;114:144-148.
3.
Afify AM, Liu J, Al-Khafaji BM: Cytologic artifacts and pitfalls of thyroid fine-needle aspiration using ThinPrep: a comparative retrospective review. Cancer 2001;93:179-186.
4.
Park ES, Cho EY, Do IG, Kim SJ, Shin JH, Han BK, Oh YL: Comparison of Liqui-PREP™ and conventional preparations in thyroid fine needle aspiration. Kor J Pathol 2009;43:550-556.
5.
Geers C, Bourgain C: Liquid-based FNAC of the thyroid: a 4-year survey with SurePath. Cancer Cytopathol 2011;119:58-67.
6.
Jung CK, Lee A, Jung ES, Choi YJ, Jung SL, Lee KY: Split sample comparison of a liquid-based method and conventional smears in thyroid fine needle aspiration. Acta Cytol 2008;52:313-319.
7.
Kim DH, Kim MK, Chae SW, Lee KB, Han EM, Kang SH, Sohn JH: The usefulness of SurePath™ liquid-based smear in sono-guided thyroid fine needle aspiration; a comparison of a conventional smear and SurePath™ liquid-based cytology. Kor J Pathol 2007;18:143-152.
8.
Michael CW, Pang Y, Pu RT, Hasteh F, Griffith KA: Cellular adequacy for thyroid aspirates prepared by ThinPrep: how many cells are needed? Diagn Cytopathol 2007;35:792-797.
9.
Cibas ES, Ali SZ: The Bethesda system for reporting thyroid cytopathology. Am J Clin Pathol 2009;132:658-665.
10.
Szporn AH, Yuan S, Wu M, Burstein DE: Cellular swirls in fine needle aspirates of papillary thyroid carcinoma: a new diagnostic criterion. Mod Pathol 2006;19:1470-1473.
11.
Kumar S, Singh N, Siddaraju N: ‘Cellular swirls' and similar structures on fine needle aspiration cytology as diagnostic clues to papillary thyroid carcinoma: a report of 4 cases. Acta Cytol 2010;54:939-942.
12.
Asioli S, Erickson LA, Sebo TJ, Zhang J, Jin L, Thompson GB, Lloyd RV: Papillary thyroid carcinoma with prominent hobnail features: a new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic, immunohistochemical, and molecular study of eight cases. Am J Surg Pathol 2010;34:44-52.
13.
Rupp M, Ehya H: Nuclear grooves in the aspiration cytology of papillary carcinoma of the thyroid. Acta Cytol 1989;33:21-26.
14.
Kini SR, Miller JM, Hamburger JI, Smith MJ: Cytopathology of papillary carcinoma of the thyroid by fine needle aspiration. Acta Cytol 1980;24:511-521.
15.
Auger M, Stelow EB, Yang GCH, Sanchez MA, Asa SL, Livolsi VA: The Bethesda System for Reporting Thyroid Cytopathology. New York, Springer, 2009, pp 91-116.
16.
Demay RM: The Art and Science of Cytopatholgy. Chicago, American Society of Clinical Pathologists, 1996, pp 730-734.
17.
Michael CW, McConnel J, Pecott J, Afify AM, Al-Khafaji B: Comparison of ThinPrep and TriPath PREP liquid-based preparations in nongynecologic specimens: a pilot study. Diagn Cytopathol 2001;25:177-184.
18.
Fadda G, Rossi ED: Liquid-based cytology in fine-needle aspiration biopsies of the thyroid gland. Acta Cytol 2011;55:389-400.
19.
Tang W, Nakamura Y, Zuo H, Yasuoka H, Yang Q, Wang X, Nakamura M, Mori I, Miyauchi A, Kakudo K: Differentiation, proliferation and retinoid receptor status of papillary carcinoma of the thyroid. Pathol Int 2003;53:204-213.
20.
Kakudo K, Tang W, Ito Y, Mori I, Nakamura Y, Miyauchi A: Papillary carcinoma of the thyroid in Japan: subclassification of common type and identification of low risk group. J Clin Pathol 2004;57:1041-1046.
21.
Liu Z, Kakudo K, Bai Y, Li Y, Ozaki T, Miyauchi A, Taniguchi E, Mori I: Loss of cellular polarity/cohesiveness in the invasive front of papillary thyroid carcinoma, a novel predictor for lymph node metastasis; possible morphological indicator of epithelial mesenchymal transition. J Clin Pathol 2011;64:325-329.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.